who should not take tirzepatide Why Am I Losing Weight on Tirzepatide? Closest medical alternatives to tirzepatide:

All major clinical trials and FDA approval pathways for semaglutide were built on once-weekly dosing schedules

SLC7A1 overexpression is involved in energy metabolism reprogramming to induce tumor progression in epithelial ovarian cancer and is associated with immune-infiltrating cells

Possible side effects include allergic reactions, skin rashes, or more severe complications such as liver damage when misused or administered incorrectly

The incorporation of a ruthenium catalyst and carbon fluorinated moieties into polymeric nanoreactors is expected to provide an anticancer strategy for tumor-targeted catalytic anticancer therapy of hypoxic tumors

GLP-1 is released after eating and has a few important roles in digestion and metabolism